EPZ-015866
CAS No. 1616391-87-7
EPZ-015866 ( GSK-591 | GSK-3203591 )
产品货号. M12360 CAS No. 1616391-87-7
EPZ-015866 (GSK-591, GSK-3203591) 是一种有效的选择性蛋白甲基转移酶 5 (PRMT5) 抑制剂,IC50 为 4 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥443 | 有现货 |
|
| 5MG | ¥867 | 有现货 |
|
| 10MG | ¥1416 | 有现货 |
|
| 25MG | ¥2762 | 有现货 |
|
| 50MG | ¥4259 | 有现货 |
|
| 100MG | ¥5877 | 有现货 |
|
| 500MG | ¥11880 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥934 | 有现货 |
|
生物学信息
-
产品名称EPZ-015866
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述EPZ-015866 (GSK-591, GSK-3203591) 是一种有效的选择性蛋白甲基转移酶 5 (PRMT5) 抑制剂,IC50 为 4 nM。
-
产品描述EPZ-015866 (GSK-591, GSK-3203591) is a potent, selective protein methyltransferase 5 (PRMT5) inhibitor with IC50 of 4 nM; shows excellent selectivity against other PMT enzymes observed with EPZ015666; inhibits the proliferation of Z-138 cells with IC50 of 62 nM.
-
体外实验GSK591 (5 μM; MCF7, T47D, and MCF10A cells) treatment suppresses breast cancer stem cells (BCSCs) proliferation and self-renewal. GSK591 reduces BCSCs numbers in vitro. Cell Proliferation Assay Cell Line:MCF7, T47D, and MCF10A cells Concentration:5 μM Incubation Time:Result:Suppressed BCSCs proliferation and self-renewal.
-
体内实验——
-
同义词GSK-591 | GSK-3203591
-
通路Chromatin/Epigenetic
-
靶点HMTase
-
受体PRMT5
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number1616391-87-7
-
分子量380.4833
-
分子式C22H28N4O2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(NC[C@H](O)CN1CCC(C=CC=C2)=C2C1)C3=CC(NC4CCC4)=NC=C3
-
化学全称4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Duncan KW, et al. ACS Med Chem Lett. 2015 Dec 2;7(2):162-6.
2.?Gerhart SV, et al. Sci Rep. 2018 Jun 26;8(1):9711.
021-51111890
购物车()
sales@molnova.cn

